Pancreatic Cancer Research

ResearcherPeking University Cancer HospitalActive in the last 2 years

Jianhui Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3482-3876; OpenAlex author ID A5101495159. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 2 papers · 2026: 1 paper

Papers 6

  1. Chinese expert consensus on precision testing and molecular diagnosis of pancreatic cancer (2025). First author DOI 10.1038/s41416-026-03522-x↗
  2. Core-fucosylated glycoproteins as biomarkers for diagnosing pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.ijbiomac.2025.146774↗
  3. Integrative Single-Cell and Spatial Transcriptomics Analysis Reveals ECM-remodeling Cancer-associated Fibroblast-Derived POSTN as a Key Mediator in Pancreatic … Last author DOI 10.7150/ijbs.108618↗
  4. Identification of the γ-glutamyl cycle as a novel therapeutic target and 5-oxoproline as a new biomarker for diagnosing pancreatic cancer. Co-author DOI 10.1080/07853890.2023.2242247↗
  5. Identification of an Immune-Related Signature for Predicting Prognosis in Patients With Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2020.618215↗
  6. T cell receptor β-chain repertoire analysis of tumor-infiltrating lymphocytes in pancreatic cancer. Co-author DOI 10.1111/cas.13877↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chunyi Hao · 6 shared papers, 2019–2026 · strength 1.14
  2. Weijia Wang · 2 shared papers, 2020–2023 · strength 0.30
  3. Wantao Ying · 1 shared paper, 2025 · strength 0.28
  4. Xinyu Zhao · 1 shared paper, 2025 · strength 0.28
  5. Yifan Wu · 1 shared paper, 2025 · strength 0.23
  6. Wei Li · 1 shared paper, 2026 · strength 0.23
  7. Haitao Zhang · 1 shared paper, 2026 · strength 0.23
  8. Guang Tan · 1 shared paper, 2026 · strength 0.23
  9. Ke Cheng · 1 shared paper, 2026 · strength 0.23
  10. Liwei Wang · 1 shared paper, 2026 · strength 0.23
  11. Huanji Xu · 1 shared paper, 2026 · strength 0.23
  12. Dan Cao · 1 shared paper, 2026 · strength 0.23
  13. Jiujie Cui · 1 shared paper, 2026 · strength 0.23
  14. Kuirong Jiang · 1 shared paper, 2026 · strength 0.23
  15. Qi Li · 1 shared paper, 2026 · strength 0.23
  16. Guanghai Dai · 1 shared paper, 2026 · strength 0.23
  17. Shukui Qin · 1 shared paper, 2026 · strength 0.23
  18. Min Zhao · 1 shared paper, 2023 · strength 0.18
  19. Dao-Ning Liu · 1 shared paper, 2023 · strength 0.18
  20. Qin Tan · 1 shared paper, 2019 · strength 0.09
  21. Can Cui · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.